Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Vannini I, et al. Among authors: gitlitz bj. Nat Commun. 2018 Jan 8;9(1):160. doi: 10.1038/s41467-017-02485-1. Nat Commun. 2018. PMID: 29311577 Free PMC article.
Epigenetic therapy in lung cancer.
Liu SV, Fabbri M, Gitlitz BJ, Laird-Offringa IA. Liu SV, et al. Among authors: gitlitz bj. Front Oncol. 2013 May 30;3:135. doi: 10.3389/fonc.2013.00135. eCollection 2013. Front Oncol. 2013. PMID: 23755372 Free PMC article.
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Vannini I, et al. Among authors: gitlitz bj. Nat Commun. 2017 Nov 27;8(1):1801. doi: 10.1038/s41467-017-01562-9. Nat Commun. 2017. PMID: 29180617 Free PMC article.
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
Gitlitz BJ, Tsao-Wei DD, Groshen S, Davies A, Koczywas M, Belani CP, Argiris A, Ramalingam S, Vokes EE, Edelman M, Hoffman P, Ballas MS, Liu SV, Gandara DR. Gitlitz BJ, et al. J Thorac Oncol. 2012 Mar;7(3):574-8. doi: 10.1097/JTO.0b013e31823f43ca. J Thorac Oncol. 2012. PMID: 22198425 Free PMC article. Clinical Trial.
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.
Liu SV, Groshen SG, Kelly K, Reckamp KL, Belani C, Synold TW, Goldkorn A, Gitlitz BJ, Cristea MC, Gong IY, Semrad TJ, Xu Y, Xu T, Koczywas M, Gandara DR, Newman EM. Liu SV, et al. Among authors: gitlitz bj. Cancer Chemother Pharmacol. 2018 Oct;82(4):723-732. doi: 10.1007/s00280-018-3672-y. Epub 2018 Aug 20. Cancer Chemother Pharmacol. 2018. PMID: 30128950 Free PMC article. Clinical Trial.
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303).
Reckamp KL, Frankel PH, Ruel N, Mack PC, Gitlitz BJ, Li T, Koczywas M, Gadgeel SM, Cristea MC, Belani CP, Newman EM, Gandara DR, Lara PN Jr. Reckamp KL, et al. Among authors: gitlitz bj. Front Oncol. 2019 Mar 11;9:132. doi: 10.3389/fonc.2019.00132. eCollection 2019. Front Oncol. 2019. PMID: 30915273 Free PMC article.
Immunotherapy and gene therapy.
Gitlitz BJ, Belldegrun A, Figlin RA. Gitlitz BJ, et al. Semin Urol Oncol. 1996 Nov;14(4):237-43. Semin Urol Oncol. 1996. PMID: 8946624 Review.
Adoptive cellular therapy.
Hoffman DM, Gitlitz BJ, Belldegrun A, Figlin RA. Hoffman DM, et al. Among authors: gitlitz bj. Semin Oncol. 2000 Apr;27(2):221-33. Semin Oncol. 2000. PMID: 10768601 Review.
76 results